Helping NET Cancer patients get a timely diagnosis,
the best care and ultimately a cure
If you don’t suspect it you can’t detect it
84% of NET patients
Their needs for information about treatment
options were not met at the time of diagnosis.
58% of NET patients are
diagnosed at an advanced stage
How Can I Help?
This August, the Pheo Para Alliance will hold two live webinar series with experts to discuss key pheo para topics. Attendance is free upon registration at pheopara.org. These hour-long webinars will provide an opportunity for the community to ask questions live or...read more
INCA Manuscript on French Patient-Reported Experience of Diagnosis, Management and Burden of Neuroendocrine Tumors to be Published in The International Journal of Endocrine Oncology
The first Global Survey of NET patients, a collaboration between INCA and Novartis, continues to have an impact worldwide with results published in medical journals. We are excited to announce that the manuscript, “French Patient-Reported Experience of Diagnosis,...read more
The Middle East Neuroendocrine Tumor Society (MENETS) has been working since 2019 on developing a NET Nutrition eBook in Hebrew, Arabic, and Russian. The book incorporates localization for the Mediterranean region. Its Hebrew version will be released on August 10th,...read more